Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

DNLI

Denali Therapeutics Inc

May 29 • 04:00PM ET

21.04

+0.09 0.43 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: ACAD XENE AXSM BMRN VKTX INCY NBIX MDGL KROS BIIB

| Held by: VTI IWM XBI VB VBK VXF IWN IBB SCHA VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.88	Insider Own	10.78%	Shs Outstand	158.66M	Perf Week	9.02%
Market Cap	3.34B	Forward P/E	-	EPS next Y	-2.43	Insider Trans	-0.31%	Shs Float	148.75M	Perf Month	13.12%
Enterprise Value	2.39B	PEG	-	EPS next Q	-0.59	Inst Own	96.23%	Short Float	9.43%	Perf Quarter	-0.66%
Income	-508.02M	P/S	-	EPS this Y	17.10%	Inst Trans	0.85%	Short Ratio	7.90	Perf Half Y	9.98%
Sales	0.00M	P/B	3.60	EPS next Y	1.34%	ROA	-40.04%	Short Interest	14.03M	Perf YTD	27.44%
Book/sh	5.84	P/C	3.38	EPS next 5Y	30.45%	ROE	-49.59%	52W High	23.77 -11.49%	Perf Year	55.39%
Cash/sh	6.22	P/FCF	-	EPS past 3/5Y	-4.56% -	ROIC	-53.12%	52W Low	12.58 67.25%	Perf 3Y	-29.77%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.60% 5.02%	Perf 5Y	-66.91%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-7.88%	Oper. Margin	-	ATR (14)	0.97	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.28	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	60.80	Recom	1.16
Dividend Gr. 3/5Y	- -	Current Ratio	9.28	EPS Q/Q	11.38%	SMA20	8.61%	Beta	1.02	Target Price	34.13
Payout	-	Debt/Eq	0.04	Sales Q/Q	-	SMA50	6.87%	Rel Volume	0.93	Prev Close	20.95
Employees	503	LT Debt/Eq	0.03	Earnings	May 07 AMC	SMA200	17.14%	Avg Volume	1.78M	Price	21.04
IPO	Dec 08, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	4.60% -100.00%	Trades		Volume	1,642,979	Change	0.43%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)